Cheng‐Lung Hsu

1.2k total citations
46 papers, 881 citations indexed

About

Cheng‐Lung Hsu is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Cheng‐Lung Hsu has authored 46 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Otorhinolaryngology and 16 papers in Surgery. Recurrent topics in Cheng‐Lung Hsu's work include Head and Neck Cancer Studies (22 papers), Viral-associated cancers and disorders (8 papers) and Lung Cancer Research Studies (6 papers). Cheng‐Lung Hsu is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Viral-associated cancers and disorders (8 papers) and Lung Cancer Research Studies (6 papers). Cheng‐Lung Hsu collaborates with scholars based in Taiwan, United States and China. Cheng‐Lung Hsu's co-authors include Kai‐Ping Chang, Shu‐Hang Ng, Ngan‐Ming Tsang, Sheng-Chieh Chan, Yu‐Sun Chang, Chun‐Ta Liao, Li‐Yu Lee, Tzu‐Chen Yen, Hung‐Ming Wang and Hung‐Ming Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Cheng‐Lung Hsu

43 papers receiving 869 citations

Peers

Countries citing papers authored by Cheng‐Lung Hsu

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Lung Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Lung Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Lung Hsu more than expected).

Fields of papers citing papers by Cheng‐Lung Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Lung Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Lung Hsu. The network helps show where Cheng‐Lung Hsu may publish in the future.

Co-authorship network of co-authors of Cheng‐Lung Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Lung Hsu. A scholar is included among the top collaborators of Cheng‐Lung Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Lung Hsu. Cheng‐Lung Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy 2026 ·Otolaryngology ·(unknown), Cheng-Yu Lin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cheng‐Lung Hsu, (unknown), Kai‐Ping Chang	0
2	The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletions 2024 ·Neoplasia ·Jen‐Fen Fu, Cheng‐Lung Hsu, Ping‐Chih Hsu	1
3	Postradiotherapy Response Assessment Using 18F-FDG PET/CT in Salivary Gland Carcinoma—A Multicenter Study 2024 ·Clinical Nuclear Medicine ·Po‐Lin Chen, Nai‐Ming Cheng, Chien‐Yu Lin, Kai‐Ping Chang, Yi‐An Lu, (unknown), Miao‐Fen Chen, Fu-Min Fang, Cheng‐Lung Hsu, Cheng‐En Hsieh	0
4	Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways 2023 ·Translational Oncology ·Hsin‐Pai Li, Chen‐Yang Huang, Kar‐Wai Lui, Yin‐Kai Chao, Chun‐Nan Yeh, Li‐Yu Lee, Yenlin Huang, Tung‐Liang Lin, (unknown), Meiyuan Huang, (unknown), (unknown), Chia‐Hsun Hsieh, Kai‐Ping Chang, Chien‐Yu Lin, Hung‐Ming Wang, Mei Chao, (unknown), Yu‐Sun Chang, Cheng‐Lung Hsu	3
5	Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension 2022 ·Frontiers in Oncology ·Pei‐Wei Huang, Chien-Yu Lin, Li‐Yu Lee, Chia‐Hsun Hsieh, Cheng‐Lung Hsu, Chi‐Ting Liau, Kang‐Hsing Fan, Shiang‐Fu Huang, Chun‐Ta Liao, (unknown), Hung‐Ming Wang	2
6	Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein–Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma 2022 ·Radiotherapy and Oncology ·Eric Yi-Liang Shen, Tsung‐Min Hung, Din‐Li Tsan, Nai‐Ming Cheng, Chung‐Jan Kang, Shiang‐Fu Huang, Cheng‐Lung Hsu, Chien‐Yu Lin, Hung‐Ming Wang, Chia‐Hsun Hsieh, Ann‐Joy Cheng, Kang‐Hsing Fan, Joseph Tung‐Chieh Chang	7
7	Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment 2021 ·Cancers ·Hsin‐Pai Li, Chen‐Yang Huang, Kar‐Wai Lui, Yin‐Kai Chao, Chun‐Nan Yeh, Li‐Yu Lee, Yenlin Huang, Tung‐Liang Lin, (unknown), Meiyuan Huang, (unknown), Yuan‐Ming Yeh, (unknown), (unknown), Chia‐Hsun Hsieh, Kai‐Ping Chang, Chien‐Yu Lin, Hung‐Ming Wang, Yu‐Sun Chang, Cheng‐Lung Hsu	11
8	A Patient-Derived Xenograft Model of Dedifferentiated Endometrial Carcinoma: A Proof-of-Concept Study for the Identification of New Molecularly Informed Treatment Approaches 2021 ·Cancers ·Chiao‐Yun Lin, Ren‐Chin Wu, Chen‐Yang Huang, Chyong‐Huey Lai, An‐Shine Chao, Hsin‐Pai Li, Chia-Lung Tsai, (unknown), Cheng‐Lung Hsu, Angel Chao	7
9	Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma 2020 ·Oral Oncology ·(unknown), Sheng-Chieh Chan, Nai‐Ming Cheng, Chun‐Ta Liao, Cheng‐Lung Hsu, Hung‐Ming Wang, Chien‐Yu Lin, Joseph Tung‐Chieh Chang, Shu‐Hang Ng, Lan‐Yan Yang, Tzu‐Chen Yen	10
10	Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma 2020 ·Head and Neck Pathology ·Yi‐Chan Lee, Li‐Yu Lee, Ngan‐Ming Tsang, Cheng‐Lung Hsu, Li‐Jen Hsin, Tseng‐tong Kuo, Kai‐Ping Chang	0
11	Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial 2019 ·Journal of Cancer Research and Clinical Oncology ·Chia‐Hsun Hsieh, Chien‐Yu Lin, Cheng‐Lung Hsu, Kang‐Hsing Fan, Shiang‐Fu Huang, Chun‐Ta Liao, Li‐Yu Lee, (unknown), Tzu‐Chen Yen, Joseph Tung‐Chieh Chang, Jr‐Rung Lin, Hung‐Ming Wang	29
12	Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway 2019 ·Cancer Medicine ·(unknown), Chun‐Nan OuYang, Hsuan Liu, Mei Chao, Ji‐Dung Luo, Cheng‐Yang Lee, Yen‐Jung Lu, I‐Che Chung, Lih‐Chyang Chen, (unknown), Ngan‐Ming Tsang, Kai‐Ping Chang, Cheng‐Lung Hsu, Hsin‐Pai Li, Yu‐Sun Chang	13
13	Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer 2016 ·Journal of the Formosan Medical Association ·Hung‐Ming Wang, Chien‐Yu Lin, Chia‐Hsun Hsieh, Cheng‐Lung Hsu, Kang‐Hsing Fan, Joseph Tung‐Chieh Chang, Shiang‐Fu Huang, Chung‐Jan Kang, Chun‐Ta Liao, Shu‐Hang Ng, Tzu‐Chen Yen	28
14	Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma 2015 ·Medicine ·(unknown), Huang‐Kai Kao, Cheng‐Lung Hsu, Jung‐Ju Huang, Li‐Yu Lee, Yenlin Huang, (unknown), Ngan‐Ming Tsang, Yu‐Liang Chang, Kai‐Ping Chang	71
15	Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts 2014 ·Journal of Investigative Dermatology ·Yueh‐Te Lin, (unknown), Ming–Heng Wu, I‐Shan Hsieh, (unknown), Cheng‐Lung Hsu, Tse‐Ming Hong, Yuh‐Ling Chen	59
16	Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy 2013 ·Annals of Nuclear Medicine ·Sheng-Chieh Chan, (unknown), Hung‐Ming Wang, Joseph Tung‐Chieh Chang, Chien‐Yu Lin, Shu‐Hang Ng, Cheng‐Lung Hsu, Kai‐Ping Chang, Chun‐Ta Liao, (unknown), Tzu‐Chen Yen	16
17	Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma 2013 ·PLoS ONE ·Li‐Jen Hsin, Huang‐Kai Kao, I‐How Chen, Ngan‐Ming Tsang, Cheng‐Lung Hsu, Shiau-Chin Liu, Yu‐Sun Chang, Kai‐Ping Chang	21
18	The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma 2012 ·Oral Oncology ·Sheng-Chieh Chan, Cheng‐Lung Hsu, Tzu‐Chen Yen, Shu‐Hang Ng, Chun‐Ta Liao, Hung‐Ming Wang	40
19	Plasma epstein‐barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma 2011 ·Head & Neck ·Cheng‐Lung Hsu, Kai‐Ping Chang, Chien‐Yu Lin, Hsien‐Kun Chang, Cheng‐Hsu Wang, Tung‐Liang Lin, Chun‐Ta Liao, Ngan‐Ming Tsang, Li‐Yu Lee, (unknown), Shu‐Hang Ng, Hsin‐Pai Li, Yu‐Sun Chang, Hung‐Ming Wang	54
20	A new prostate cancer therapeutic approach: Combination of androgen ablation with COX‐2 inhibitor 2008 ·International Journal of Cancer ·Yi Cai, Yi‐Fen Lee, Gonghui Li, Su Liu, Bo‐Ying Bao, Jiaoti Huang, Cheng‐Lung Hsu, Chawnshang Chang	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact